85 related articles for article (PubMed ID: 9220143)
21. Sex hormone binding globulin and aging.
Caldwell JD; Jirikowski GF
Horm Metab Res; 2009 Mar; 41(3):173-82. PubMed ID: 18956301
[TBL] [Abstract][Full Text] [Related]
22. Opposing effects of estradiol- and testosterone-membrane binding sites on T47D breast cancer cell apoptosis.
Kampa M; Nifli AP; Charalampopoulos I; Alexaki VI; Theodoropoulos PA; Stathopoulos EN; Gravanis A; Castanas E
Exp Cell Res; 2005 Jul; 307(1):41-51. PubMed ID: 15922725
[TBL] [Abstract][Full Text] [Related]
23. Concentration-dependent mitogenic and antiproliferative actions of 2-methoxyestradiol in estrogen receptor-positive human breast cancer cells.
Liu ZJ; Zhu BT
J Steroid Biochem Mol Biol; 2004 Mar; 88(3):265-75. PubMed ID: 15120420
[TBL] [Abstract][Full Text] [Related]
24. Effect of Org OD14 (LIVIAL) and its metabolites on human estrogen sulphotransferase activity in the hormone-dependent MCF-7 and T-47D, and the hormone-independent MDA-MB-231, breast cancer cell lines.
Chetrite GS; Kloosterboer HJ; Philippe JC; Pasqualini JR
Anticancer Res; 1999; 19(1A):269-75. PubMed ID: 10226553
[TBL] [Abstract][Full Text] [Related]
25. Association of bioavailable estradiol levels and testosterone levels with serum albumin levels in elderly men.
Hayashi T; Yamada T
Aging Male; 2008 Jun; 11(2):63-70. PubMed ID: 18570057
[TBL] [Abstract][Full Text] [Related]
26. Interaction of testosterone-oestradiol binding globulin (TeBG) and albumin with human prostatic carcinoma in vitro.
Shiina H; Ishibe T; Usui T
Int Urol Nephrol; 1993; 25(6):577-82. PubMed ID: 8175278
[TBL] [Abstract][Full Text] [Related]
27. Human breast cancer cells and normal mammary epithelial cells: retinol metabolism and growth inhibition by the retinol metabolite 4-oxoretinol.
Chen AC; Guo X; Derguini F; Gudas LJ
Cancer Res; 1997 Oct; 57(20):4642-51. PubMed ID: 9377581
[TBL] [Abstract][Full Text] [Related]
28. Phytoestrogen exposure correlation with plasma estradiol in postmenopausal women in European Prospective Investigation of Cancer and Nutrition-Norfolk may involve diet-gene interactions.
Low YL; Taylor JI; Grace PB; Dowsett M; Scollen S; Dunning AM; Mulligan AA; Welch AA; Luben RN; Khaw KT; Day NE; Wareham NJ; Bingham SA
Cancer Epidemiol Biomarkers Prev; 2005 Jan; 14(1):213-20. PubMed ID: 15668497
[TBL] [Abstract][Full Text] [Related]
29. Expression of sex hormone-binding globulin (SHBG) in human granulosa-lutein cells.
Forges T; Gérard A; Hess K; Monnier-Barbarino P; Gérard H
Mol Cell Endocrinol; 2004 Apr; 219(1-2):61-8. PubMed ID: 15149727
[TBL] [Abstract][Full Text] [Related]
30. Estrogen receptor-alpha regulates the degradation of insulin receptor substrates 1 and 2 in breast cancer cells.
Morelli C; Garofalo C; Bartucci M; Surmacz E
Oncogene; 2003 Jun; 22(26):4007-16. PubMed ID: 12821935
[TBL] [Abstract][Full Text] [Related]
31. O-Glycosylation of human sex hormone-binding globulin is essential for inhibition of estradiol-induced MCF-7 breast cancer cell proliferation.
Raineri M; Catalano MG; Hammond GL; Avvakumov GV; Frairia R; Fortunati N
Mol Cell Endocrinol; 2002 Mar; 189(1-2):135-43. PubMed ID: 12039072
[TBL] [Abstract][Full Text] [Related]
32. Albumin possesses intrinsic enolase activity towards dihydrotestosterone which can differentiate benign from malignant breast tumors.
Drmanovic Z; Voyatzi S; Kouretas D; Sahpazidou D; Papageorgiou A; Antonoglou O
Anticancer Res; 1999; 19(5B):4113-24. PubMed ID: 10628362
[TBL] [Abstract][Full Text] [Related]
33. Control of the membrane sex hormone-binding globulin-receptor (SHBG-R) in MCF-7 cells: effect of locally produced SHBG.
Fortunati N; Raineri M; Cignetti A; Hammond GL; Frairia R
Steroids; 1998; 63(5-6):282-4. PubMed ID: 9618786
[TBL] [Abstract][Full Text] [Related]
34. The control of progesterone receptor expression in MCF-7 breast cancer cells: effects of estradiol and sex hormone-binding globulin (SHBG).
Fazzari A; Catalano MG; Comba A; Becchis M; Raineri M; Frairia R; Fortunati N
Mol Cell Endocrinol; 2001 Feb; 172(1-2):31-6. PubMed ID: 11165037
[TBL] [Abstract][Full Text] [Related]
35. Development of a breast cancer screening & research program.
Jackson PM; Jackson GL; Kemp K; Bauman DH; Ota DM; Jones LA
Prog Clin Biol Res; 1986; 216():71-8. PubMed ID: 3725806
[No Abstract] [Full Text] [Related]
36. Novel signaling molecules implicated in tumor-associated fatty acid synthase-dependent breast cancer cell proliferation and survival: Role of exogenous dietary fatty acids, p53-p21WAF1/CIP1, ERK1/2 MAPK, p27KIP1, BRCA1, and NF-kappaB.
Menendez JA; Mehmi I; Atlas E; Colomer R; Lupu R
Int J Oncol; 2004 Mar; 24(3):591-608. PubMed ID: 14767544
[TBL] [Abstract][Full Text] [Related]
37. 17 beta-estradiol-regulated expression of protein tyrosine phosphatase gamma gene in cultured human normal breast and breast cancer cells.
Zheng J; Kulp SK; Zhang Y; Sugimoto Y; Dayton MA; Govindan MV; Brueggemeier RW; Lin YC
Anticancer Res; 2000; 20(1A):11-9. PubMed ID: 10769629
[TBL] [Abstract][Full Text] [Related]
38. Differential expression of the mannose 6-phosphate/ insulin-like growth factor-II receptor in human breast cancer cell lines of different invasive potential.
Xie S; Kang JX
Med Sci Monit; 2002 Aug; 8(8):BR293-300. PubMed ID: 12165733
[TBL] [Abstract][Full Text] [Related]
39. The role of albumin in the calculation of free and bioavailable testosterone in women with hyperandrogenemia.
Mueller A; Cupisti S; Binder H; Hoffmann I; Beckmann MW; Dittrich R
In Vivo; 2006; 20(3):403-7. PubMed ID: 16724679
[TBL] [Abstract][Full Text] [Related]
40. Association of breast cancer risk with a common functional polymorphism (Asp327Asn) in the sex hormone-binding globulin gene.
Cui Y; Shu XO; Cai Q; Jin F; Cheng JR; Cai H; Gao YT; Zheng W
Cancer Epidemiol Biomarkers Prev; 2005 May; 14(5):1096-101. PubMed ID: 15894658
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]